Photo: Peter Searle
|
SUPPORT FOR THE FAINT OF HEART: Adam Hart [below, at the London Stock
Exchange] is a Nominated Advisor, or Nomad, who
offers guidance to client companies.
|
Protonex Technology Corp. is a company in
Southborough, Mass., that develops fuel-cell systems for
military and commercial applications. By early 2006, it
had raised private equity from venture capital investors
twice and was ready to go public. Protonex was seeking
money for R&D, commercialization of new products,
and overseas expansion at a time when alternative
energy companies were being well received in equity
markets in countries that had signed the Kyoto Protocol.
While Protonex did consider NASDAQ, the stalwart of
technology stock markets, for its initial public
offering (IPO), it concluded that this was not the best
option.
“Early-stage technology companies with low revenue
[and] no profits but a lot of potential are typically
too small for today’s NASDAQ market,” says Protonex CEO
Scott Pearson. What’s more, it would have been
“financially difficult” to comply with the demanding
reporting required under the Sarbanes-Oxley rules
adopted by the United States in the wake of the Enron
and Worldcom scandals.
So, in July 2006, Protonex turned instead to London’s
Alternative Investment Market (AIM) to raise
US $16.2 million in equity capital. “We ended up very
pleased,” says Pearson, who reports that the company’s
share price has risen more than 12 percent since the
IPO. “Our AIM listing gave us an awareness and
credibility outside the U.S. market. We are not viewed
as just an American company anymore.”
For small to midsize technology companies like
Protonex—short on capital but long on global
ambitions—AIM is fast becoming the IPO market of choice.
“Fifteen or 20 years ago a start-up company would go on
NASDAQ and raise $40 million or less and get good
coverage from analysts and a robust market for its
shares following the issue,” says Bryce Linsenmayer, a
corporate and securities attorney with Haynes and Boone,
in Houston. “But you can’t do a deal like that in the
States anymore.”
The NASDAQ electronic market, founded in 1971, for
many years offered U.S. entrepreneurs access to public
equity. But these days NASDAQ is setting its sights on
larger corporations, the likes of Google and Microsoft.
Also, fewer and fewer U.S. analysts have been covering
the financial progress of smaller public companies since
the dot-com bubble burst, making it more difficult for
these firms to keep investors interested after the IPO.
Jim Poage, president of The San Antonio Technology
Accelerator Initiative, a not-for-profit organization
that offers advice and support to local technology-based
companies, finds the shrinking opportunities for smaller
firms in the U.S. public equity market worrisome. “New
companies are the lifeblood of our system,” he says.
“And if you withdraw one of the major carrots of
financial reward, that is a very troubling macroeconomic
trend.”
AIM, launched as a submarket of the London Stock
Exchange in 1995, has recently stepped in to fill the
breach left by NASDAQ, aggressively marketing to U.S.
companies. As of the end of September 2006, 47 U.S.
companies were listed on AIM; 16 of those (34 percent)
had joined in the first nine months of 2006.
One of AIM’s attractions is that it requires no
minimum capitalization or issue size. (A company’s
capitalization is its share price multiplied by the
number of shares outstanding; issue size is the number
of shares sold at one time multiplied by the price per
share.) The average capitalization of an AIM IPO issuer
is $90 million, and the average issue size is $30
million to $40 million.
Nominated Advisors, known as Nomads, are a unique
feature [see photo, “Support for the Faint of Heart”].
These investment advisors, licensed by the London Stock
Exchange and handpicked by AIM, guide issuers through
the process of coming to market, preparing the
prospectus, and vouching for the company’s investment
potential. Nomads are directly responsible to the
exchange for the integrity of the issuers they bring to
market—AIM issuers do not have to file with any UK
regulatory authority—and often act as brokers, setting
the initial share price and helping buy and sell the
shares after issue.
Unlike the brokers and investment banks that bring
companies to the public market in the United States,
whose relationships with a company often end after the
IPO launch, Nomads are required under AIM rules to
continue to guide and monitor a company in the years
following the IPO. They take the role very seriously.
“It’s a virtuous circle you get into if you associate
with companies that grow and make money for investors,”
says Adam Hart, head of business development for the
London Nomad company KBC Peel Hunt. “If your client
company goes bad, it’s bad for you.”
Anne Moulier, head of U.S. Business Development for
AIM, puts it more bluntly: “Nomads build their
reputation on the back of AIM. If they lose their AIM
license, they lose their business.”
Because the listing process is streamlined and
straightforward for AIM companies, the lead time to
market is relatively short—as little as six weeks.
Compare that with the four to six months required for a
company to be ready for a NASDAQ issue. Since Congress
passed the Public Company Accounting Reform and Investor
Protection Act (also known as the Sarbanes-Oxley Act),
domestic public markets issuers face a big increase in
financial and corporate governance reporting
requirements. Section 404 of Sarbanes-Oxley, which
requires companies to assess the effectiveness of their
internal controls at the end of every fiscal year, has
presented particular compliance challenges for small
companies.
Another attractive feature of AIM is that a company,
once listed, can dip back into the market for additional
capital in a matter of days, giving it the flexibility
to move quickly when acquisition opportunities arise.
Companies listed on U.S. exchanges are required to
consult shareholders every time they come to market for
equity capital.
Overall, NASDAQ has a higher number of buyers and
sellers on a given day than AIM. That is, it is more
liquid. But AIM is more liquid for shares of companies
valued between $100 million and $200 million. In
particular, AIM can deliver on liquidity events, such as
IPOs, Moulier observes. By October, companies had raised
$18 billion on AIM this year, while NASDAQ companies had
raised only $8 billion.
The total cost of raising capital on AIM is also
substantially lower than on NASDAQ, according to the
Canadian investment bank and Nomad company Canaccord
Adams. The total approximate cost for a small-cap
company coming to market on AIM, Canaccord reports, is
$922 000, versus $2.3 million on NASDAQ.
Unlike the U.S. Securities and Exchange Commission,
which requires companies to file quarterly financial
reports, AIM requires only semiannual reports. “When you
have to focus [just on] every 90 days, it can create
behaviors that are not always optimal for building
longer-term value,” says Stephen Dixon, CFO of Carlsbad,
Calif.–based Alphatec Holdings, a $160 million cap
medical device company that raised $83 million on NASDAQ
earlier this year. In contrast, AIM’s reporting
requirements reflect the longer-term investment horizon
of its institutional investors—three to five years out.
“AIM is set up with the appropriate rules and
regulations for smaller companies,” says Hart, of KBC
Peel Hunt. “Some say it is a ‘light’ touch. The AIM
rulebook is very small; it runs to 30 pages. Put that up
against the SEC and NASDAQ rules, and I know which
market I would like to apply to.”